Unicycive Therapeutics UNCY
NASDAQ UNCY
$3.94 +0.07 (+1.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Unicycive Therapeutics (UNCY) Return on Assets [ROA] (2021 - 2026)

Updated

Unicycive Therapeutics (UNCY) posted Return on Assets [ROA] of -46.50% for Q2 2026, up 55.04 percentage points from -101.54% a year earlier and up 4.31 percentage points from the prior quarter.

Analysis

Unicycive Therapeutics (UNCY) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Unicycive Therapeutics' Return on Assets [ROA] came in at -70.73%, up 64.15 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a four-year change of +30.65 percentage points (FY2021 to FY2025).
  • In prior years, Unicycive Therapeutics' Return on Assets [ROA] was -134.88% in FY2024 (+103.12 pp), -238.00% in FY2023 (-70.51 pp), -167.50% in FY2022 (-66.12 pp) and -101.38% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] in data going back to Q3 2021.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last three quarters, with an average year-over-year change of +14.34 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q4 2023, with a gain of 157.56 percentage points; the weakest was Q4 2022, with a drop of 228.06 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -50.80% (Q1 2026), -57.30% (Q4 2025) and -76.03% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 8.08%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 4.65%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.45%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 9.10%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 9.29%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -6.13%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 2.14%
10 Unicycive Therapeutics 109.75 Mn -90.23 Mn - -46.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.50%
Mar 31, 2026 -50.80%
Dec 31, 2025 -57.30%
Sep 30, 2025 -76.03%
Jun 30, 2025 -101.54%
Mar 31, 2025 -99.14%
Dec 31, 2024 -88.06%
Sep 30, 2024 -67.61%
Jun 30, 2024 -57.74%
Mar 31, 2024 -75.69%
Dec 31, 2023 -120.36%
Sep 30, 2023 -91.56%
Jun 30, 2023 -76.69%
Mar 31, 2023 -124.72%
Dec 31, 2022 -277.92%
Sep 30, 2022 -134.67%
Jun 30, 2022 -102.85%
Mar 31, 2022 -70.48%
Dec 31, 2021 -49.86%
Sep 30, 2021 -74.73%
API Access

Unicycive Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=UNCY&period=max&api_key=YOUR_API_KEY